Abstract | OBJECTIVE: STUDY DESIGN: Fifty-one postmenopausal women were randomly selected in a double-blind crossover study. The women received 2 mg of estradiol continuously during five 28-day cycles and 10 mg of medroxyprogesterone or 1 mg of norethindrone sequentially for 12 days of each cycle. Daily symptom rating scales were kept. RESULTS: CONCLUSION:
|
Authors | I Björn, M Bixo, K S Nöjd, S Nyberg, T Bäckström |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 183
Issue 6
Pg. 1419-26
(Dec 2000)
ISSN: 0002-9378 [Print] United States |
PMID | 11120505
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Progesterone Congeners
- Norethindrone Acetate
- Medroxyprogesterone Acetate
- Norethindrone
|
Topics |
- Affect
(drug effects)
- Cross-Over Studies
- Double-Blind Method
- Estrogen Replacement Therapy
(adverse effects)
- Female
- Humans
- Medical Records
- Medroxyprogesterone Acetate
(adverse effects)
- Middle Aged
- Norethindrone
(adverse effects, analogs & derivatives)
- Norethindrone Acetate
- Premenstrual Syndrome
- Progesterone Congeners
(adverse effects)
|